NCT07814118Enrolling by invitation
Multimodal Physiologic State Intelligence Study
OMNIPHYS: A Prospective Multimodal Longitudinal Study of AI-Enabled Physiologic State Modeling and Early Detection of Clinical Deterioration
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
The OMNIPHYS study will investigate whether multimodal ultrasound and other routinely collected clinical and physiologic data can be combined with artificial intelligence to characterize changes in a person's physiologic state over time. The study will examine cardiac, vascular, pulmonary, and systemic physiologic measurements and develop longitudinal models that describe baseline physiology, physiologic perturbation, compensation, deterioration, treatment response, and recovery. The study is observational and will not assign experimental treatments. The goal is to determine whether changes in multimodal physiologic patterns can be identified and characterized earlier and more reliably than conventional single-time-point assessment.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 25000 (estimated)
- First submitted
- 2 Sept 2026
- Start date
- 2 Sept 2026
- Primary completion date
- 2 Sept 2046
- Lead sponsor
- Truway Health, Inc.
- NCT number
- NCT07814118
What you commit to
- Study type: Observational
- Planned participants: 25000
- From 2 Sept 2026 to the primary completion date, 2 Sept 2046
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Conditions or circumstances that, in the judgment of the responsible clinical investigator, make participation inappropriate or prevent meaningful longitudinal follow-up.
Other
- Inability or unwillingness to provide informed consent or otherwise meet applicable consent requirements.
- Inability to obtain interpretable protocol-relevant physiologic or imaging data when such data are required for the applicable analysis.
- Withdrawal of consent or request for discontinuation of research participation where applicable.
- Any circumstance that would prevent collection, secure handling, or analysis of study data in accordance with the approved protocol and applicable requirements.
Who the study is looking for
- Adults aged 18 years or older who are capable of providing informed consent, or who meet applicable legally authorized representative requirements where permitted.
- Individuals undergoing routine clinical evaluation, diagnostic imaging, monitoring, treatment, or longitudinal follow-up, including individuals with relevant cardiovascular, vascular, pulmonary, renal, systemic, or other conditions represented within the OMNIPHYS research framework.
- Healthy volunteers without the conditions under study may participate as reference participants.
- Ability to undergo at least one protocol-relevant physiologic or imaging assessment and/or contribute eligible routinely collected clinical data.
- Availability of sufficient clinical, physiologic, imaging, or longitudinal outcome data for the applicable analysis.
- Willingness to permit collection and longitudinal analysis of protocol-defined research data in accordance with informed consent and applicable privacy and data-governance requirements.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Truway Health, Inc. Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.